Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tracks clues to predict transplant complication

NCT ID NCT04188912

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 38 times

Summary

This study followed 267 adults who had stem cell transplants to understand why some develop chronic graft-versus-host disease (GVHD), a common complication. Researchers collected blood, saliva, tears, and tissue samples, along with eye scans and breathing tests, to find early signs of the condition. The goal is to help doctors predict and detect chronic GVHD sooner.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Cleveland Clinic

    Cleveland, Ohio, 44195, United States

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

  • Moffitt Cancer Center

    Tampa, Florida, 33612, United States

  • National Cancer Institute

    Bethesda, Maryland, 20892, United States

  • Roswell Park

    Buffalo, New York, 14263, United States

  • University of Florida

    Gainesville, Florida, 32610, United States

  • Vanderbilt

    Nashville, Tennessee, 37212, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors predict and catch chronic GVHD earlier after stem cell transplants.

What could go wrong

This is an observational study, not testing a treatment. It may not lead to direct improvements for patients.

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.